Fighting tumours with magnetic bacteria

Researchers at ETH Zurich are planning to use magnetic bacteria to fight cancerous tumours

01-Nov-2022 - Scientists around the world are researching how anti-cancer drugs can most efficiently reach the tumours they target. One possibility is to use modified bacteria as “ferries” to carry the drugs through the bloodstream to the tumours. Researchers at ETH Zurich have now succeeded in controlling ...

Cancer DNA in the blood: an early warning system for recurrent tumors in children

Cell-free tumor DNA can be detected early in liquid biopsies

18-Mar-2022 - Neuroblastomas release DNA fragments into the blood and cerebrospinal fluid of patients. These genetic material can indicate a possible disease recurrence at an early stage. It also provides information about changes in certain cancer-driving genes. This is what scientists from the German ...

3D tissue structures on the chip act as organs in miniature

New organ-on-chip system enables precise monitoring of 3D tumour tissue outside the body

23-Feb-2022 - A research team around Dr. Andreas Weltin, Dr. Jochen Kieninger and Johannes Dornhof from the Department of Microsystems Engineering (IMTEK) at the University of Freiburg has developed a system that, among other things, makes it possible to study the development of tumour cells outside the human ...

A new generation of particle accelerators aims at taking cancer therapy, drug detection and material analysis to a higher level

Additively manufactured copper components for linear accelerators

04-Nov-2021 - World first: Fraunhofer IWS for the very first time prints quadrupole components for linear accelerator.These linear accelerators are so compact that they are becoming affordable even for smaller hospitals, airports and laboratories. To support this development, the Fraunhofer Institute for ...

Detailed tumour profiling

Better determine which treatment will best match every patient’s cancer and thus be most effective.

25-Jan-2021 - As part of a clinical study involving patients from the University Hospitals in Zurich and Basel, researchers are conducting a thorough and highly precise investigation into the molecular and functional properties of tumours. Their goal is to help physicians to better determine which treatment ...

Attacking tumours directly on identification

Therapy and diagnostics of tumours in only one step is possible with the aid of so-called theranostic agents

04-Sep-2020 - The combination of a biomolecule and a metal complex can target, bind, mark and damage cancer cells. A German-Spanish team has manufactured such a theranostic agent that visualises tumour cells by irradiation with visible light, and proved its effectiveness against lung cancer cells. Andres ...

Simple and Fast Method for Radiolabelling Antibodies against Breast Cancer

Using UV light, radiolabelled antibodies can be produced in just 15 minutes

24-Apr-2019 - Radioactive antibodies that target cancer cells are used for medical diagnostics with PET imaging or for targeted radioimmunotherapy. Researchers from the University of Zurich have created a new method for radiolabelling antibodies using UV light. In less than 15 minutes, the proteins are ...

New biomarker links cancer progression to genome instability

High level of specific protein in tumors indicates prognosis

14-Jan-2019 - Our DNA is under constant attack. The delicate molecule that contains our genetic information is extremely vulnerable to everything from environmental agents, such as radiation, to the chemicals in the air we breathe and the food we eat. Genome instability can lead to genetic disorders, chronic ...

Nobel Prize for Physiology or Medicine 2018 Announced

Appreciation of the research on cancer therapies

01-Oct-2018 - The researchersJames P. Allison and Tasuku Honjo were announced today as this year's winners of the Nobel Prize for Physiology or Medicine. Their achievements in the field of cancer therapy was groundbreaking and worthy of the Nobel Prize Committee's appreciation. With the help of the immune ...

Hidden signs in cancer tissue

07-Aug-2018 - When scientists at ETH Zurich analysed huge amounts of genetic cancer data, they found previously unresearched molecular changes. These could help in developing new personalised cancer treatments. A research team led by Gunnar Rätsch, Professor of Biomedical Informatics at ETH Zurich, has ...